01—Abstract
Summary
Summary of the 10-K filed February 6, 2015. Cited figures are marked; the original filing is the authoritative source.
Mettler-Toledo International Inc. (MTD) reported 2014 net sales of $2.49 billiona, up from $2.38 billion in 2013 and $2.34 billion in 2012, with net earnings of $338.2 million, or $11.44 per diluted share, compared with $306.1 million ($9.96 per diluted share) in 2013.
The company describes itself as a leading global supplier of precision instruments and services, with five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. Management attributed sales growth in 2014 to improved market conditions, especially in the United States, and strong demand from laboratory-related markets, while noting continued weakness in Chinese industrial markets and uncertainty in certain emerging markets and parts of Europe. Gross profit as a percentage of net sales rose to 54.7% from 53.9%, and operating cash flow was $418.9 millionb.
The balance sheet shows cash of $85.3 millionc and total debt of $452.0 million, with total shareholders' equity declining to $719.6 million from $935.1 million, largely due to $414.0 million of share repurchases and a $177.9 million negative swing in other comprehensive income. The company repurchased 1,617,499 shares in 2014 and had $478.4 million remaining under its $3 billion repurchase program. Historically it has not paid dividends on its common stock.
The filing also highlights risk factors tied to currency and China. Management entered into euro forward contracts in January 2015 following the Swiss National Bank's abandonment of its euro exchange rate floor, and it identifies Chinese operations as 17% of sales to external customers and 26% of segment profit in 2014. Management noted a $1.1 million to $1.3 milliond annual pre-tax earnings sensitivity to a 1% Swiss franc strengthening against the euro, before the forward contracts.
02—Key points
Key Highlights
- Net sales rose to $2,485,983 thousand in 2014 from $2,378,972 thousand in 2013; net earnings increased to $338,241 thousand from $306,094 thousand.
- Diluted earnings per share were $11.44 in 2014, versus $9.96 in 2013 and $9.14 in 2012.
- Gross profit as a percentage of net sales was 54.7% in 2014, compared with 53.9% in 2013 and 53.0% in 2012.
- Laboratory-related products represented approximately 47% of 2014 net sales and industrial-related products approximately 44%; service revenue was approximately 22% of net sales.
- Operating cash flow was $418.9 million in 2014, up from $345.9 million in 2013, with capital expenditures of $89.4 million.
- The company repurchased $414.0 million of common stock in 2014 and had $478.4 million remaining under a $3 billion repurchase program as of December 31, 2014.
- Total shareholders' equity fell to $719.6 million from $935.1 million, reflecting share repurchases and a $177.9 million negative other comprehensive income swing, largely from pension and currency effects.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-KFY2014filed February 6, 2015Financial Statements
FY2014 against FY2013
| Line item | FY2014FY2013 | Change |
|---|---|---|
| Revenue | $2.49B$2.38B | +4.5% |
| Cost of Revenue | $810.55M$795.23M | +1.9% |
| Gross Profit | $1.36B$1.28B | +6.0% |
| R&D Expenses | $123.30M$116.35M | +6.0% |
| SG&A Expenses | $728.58M$692.69M | +5.2% |
| Interest Expense | $24.54M$22.71M | +8.0% |
| Net Income | $338.24M$306.09M | +10.5% |
| EPS (Basic) | $11.71$10.22 | +14.6% |
| EPS (Diluted) | $11.44$9.96 | +14.9% |
| Shares Outstanding (Basic) | 28.89M29.95M | −3.5% |
| Shares Outstanding (Diluted) | 29.57M30.73M | −3.8% |
05—Questions
Frequently Asked Questions
How did Mettler-Toledo perform financially in 2014?
Net sales were $2,486.0 million, up 4% in U.S. dollars and 5% in local currencies from 2013. Net earnings were $338.2 million, and diluted earnings per share were $11.44, compared with $9.96 in 2013.
What drove sales growth and where are the risks?
The filing attributes 2014 growth to improved market conditions, especially in the United States, and strong laboratory-related demand. Risks noted include weak Chinese industrial market conditions, uncertain emerging markets, parts of Europe, and currency exposure, particularly between the Swiss franc, euro, and U.S. dollar.
Does Mettler-Toledo pay dividends and how is it returning capital?
The company states it has historically not paid dividends on its common stock. It returns capital through share repurchases, spending $414.0 million on 1,617,499 shares in 2014, with $478.4 million remaining under its $3 billion program.
How concentrated is the business in China and what is the currency exposure?
Chinese operations accounted for 17% of sales to external customers, approximately 30% of global production, and 26% of segment profit in 2014. In January 2015 the company entered euro forward contracts to reduce exposure after the Swiss National Bank abandoned its euro floor; absent these contracts, a 1% Swiss franc strengthening against the euro would reduce pre-tax earnings by about $1.1 million to $1.3 million annually.
What is the company's debt position?
Total debt was $452.0 million at December 31, 2014, against cash of $85.3 million. The $800 million revolving Credit Agreement, maturing November 26, 2018, had $110.8 million borrowed, and the company issued $125 million of 3.84% Senior Notes in September 2014, with another $125 million of 4.24% Senior Notes scheduled for June 2015.
06—Continue